CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BioVentrix Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BioVentrix Inc
120 Forbes Blvd., Suite 125
Phone: (302) 636-5400p:302 636-5400 MANSFIELD, MA  02048  United States
Business Summary
BioVentrix, Inc. is a medical device company focused on developing, manufacturing and commercializing devices to restore left ventricular function in heart failure patients with reduced ejection fraction (HFrEF). The Company's lead device program, the Revivent System, has a CE mark in Europe and is in a pivotal trial in the United States. The Company's Revivent System is a medical device engineered to exclude non-functional scar tissue in the left ventricular (LV), make the left ventricle smaller, restore shape, lower wall stress, increase ejection fraction, and restore efficient cardiac function. Cardiothoracic surgeons can perform the procedure on a beating heart in under ninety minutes through a mini-thoracotomy incision, making it significantly less invasive than open heart surgery. In addition to the Revivent System, the Company also has ownership rights to Alginate, a hydrogel-based device treatment for HFrEF patients without anterior scarring.
(Source: 6-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2025YesYes---

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Co-Chief Executive Officer, Chief Financial Officer DavidRichmond 53 1/15/2025 1/1/2024
President, Co-Chief Executive Officer, Director SteveChartier 57 1/15/2025 12/1/2021
Chief Medical Officer OriBen-Yehuda 66 1/1/2024 1/1/2024
3 additional Officers and Directors records available in full report.

Business Names
Business Name
BioVentrix GmbH
BVX Acquisition, Inc.
MateraCor, Inc.

General Information
Number of Employees: 5 (As of 12/31/2025)
Federal Tax Id: 200372415


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 18, 2026